Literature DB >> 11450889

Effect of perorally administered pivmecillinam on the normal oropharyngeal, intestinal and skin microflora.

A Sullivan1, C Edlund, B Svenungsson, L Emtestam, C E Nord.   

Abstract

To study the ecological effects of pivmecillinam on the human oropharyngeal, intestinal and skin microflora, 15 healthy volunteers were given pivmecillinam tablets 400 mg twice daily for 7 days. Saliva, stool and skin specimens were taken before (days -3 and 0) and on the 2nd, 4th and 7th days during the administration period and 14 and 21 days after the start of administration. Mecillinam caused no major changes in the aerobic or anaerobic oropharyngeal microflora. In the aerobic intestinal microflora there was a decrease in the numbers of Escherichia coli while no changes occurred in the anaerobic microflora. In the skin microflora there was a transient decrease in the numbers of Propionibacterium spp. underneath the wing of the nose. The major effect of pivmecillinam was seen on E. coli and to some extent on Propionibacterium spp. No further ecological disturbances were noticed in the oropharyngeal, intestinal or skin microflora.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11450889     DOI: 10.1179/joc.2001.13.3.299

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  6 in total

1.  Microflora changes with norfloxacin and pivmecillinam in women with recurrent urinary tract infection.

Authors:  Birgit Stattin Norinder; Ragnar Norrby; Ann-Chatrin Palmgren; Sofia Hollenberg; Ulla Eriksson; Carl Erik Nord
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

2.  Ecological effects of perorally administered pivmecillinam on the normal vaginal microflora.

Authors:  Asa Sullivan; Aino Fianu-Jonasson; Britt-Marie Landgren; Carl Erik Nord
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women.

Authors:  Karen Ejrnaes; Dorthe Sandvang; Bettina Lundgren; Sven Ferry; Stig Holm; Tor Monsen; Rolf Lundholm; Niels Frimodt-Moller
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

4.  High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.

Authors:  Arne Søraas; Arnfinn Sundsfjord; Silje Bakken Jørgensen; Knut Liestøl; Pål A Jenum
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

5.  Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.

Authors:  Arne Søraas; Arnfinn Sundsfjord; Irene Sandven; Cathrine Brunborg; Pål A Jenum
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

6.  Effects of treatment with antimicrobial agents on the human colonic microflora.

Authors:  Fatemeh Rafii; John B Sutherland; Carl E Cerniglia
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.